ALRISE develops controlled release depot formulations for protein, peptide and small molecule drugs. The cornerstone of ALRISE’s business is its patented parenteral drug delivery technology ImSus® for the encapsulation of active pharmaceutical ingredients in biodegradable polymeric nano- or microparticles. ALRISE offers its technology and experience to pharma-, biotech- and generic drug companies with the objective of developing new products or improving current products based on controlled release formulations. Business Areas The development of innovative solutions for target product profiles given by its partners is ALRISE’s core competence. Services mainly apply to areas of - Formulation of New Chemical Entities (in co-operation with drug developing companies) - Reformulation of pharmaceutical products in the context of Product Lifecycle Management (in co-operation with originators) - Reformulation of off-patent drugs to develop supergeneric products (in co-operation with generics companies)